The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; MSD; Novartis; Pfizer; Roche; Takeda
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; MSD; Novartis; Roche; Takeda
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb
Molecular testing, frequency of molecular alterations and targeted 1st-line treatment of patients with non-small cell lung carcinoma in Germany: First results from the prospective German Registry CRISP (AIO-TRK-0315).
 
Frank Griesinger
Honoraria - ARIAD; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Clovis Oncology; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche
Consulting or Advisory Role - ARIAD; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Clovis Oncology; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche
Research Funding - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche
 
Wilfried Ernst Erich Eberhardt
No Relationships to Disclose
 
Arnd Nusch
No Relationships to Disclose
 
Marcel Reiser
Honoraria - Bristol-Myers Squibb; Celgene; Roche
 
Mark-Oliver Zahn
Travel, Accommodations, Expenses - Gilead Sciences; Novartis
 
Norbert Walter Marschner
Honoraria - Lilly; Novartis; Roche
Consulting or Advisory Role - Lilly; Novartis; Roche
Speakers' Bureau - Lilly; Novartis; Roche
Research Funding - Celgene (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Celgene; Lilly; Novartis; Pfizer; Roche
 
Martina Jänicke
No Relationships to Disclose
 
Annette Fleitz
No Relationships to Disclose
 
Lisa Spring
No Relationships to Disclose
 
Joerg Sahlmann
No Relationships to Disclose
 
Aysun Karatas
No Relationships to Disclose
 
Annette Hipper
No Relationships to Disclose
 
Wilko Weichert
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD; Novartis; Roche; Takeda
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; MSD; Novartis; Roche; Takeda
Research Funding - Roche
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; MSD; Novartis; Roche; Takeda
 
Achim Rittmeyer
Consulting or Advisory Role - AbbVie; AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Pfizer; Roche/Genentech
Speakers' Bureau - Bristol-Myers Squibb; Lilly; MSD; Roche/Genentech
 
Martin Metzenmacher
Consulting or Advisory Role - MSD; Novartis; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Cornelius F. Waller
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Mylan; Roche; Teva
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Martin Sebastian
No Relationships to Disclose
 
Michael Thomas
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer; Roche
Research Funding - AstraZeneca (Inst); MSD (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer; Roche